Key Takeaways
- Moolec Science entered into a Business Combination Agreement with Bioceres Group, Nutrecon, and Gentle Technologies Corp.
- The transaction will create an expanded organization focused on molecular farming, biological agriculture, and biotech manufacturing.
- The copmany will integrate new technologies and services across food, agriculture, and materials sectors.
- Operational efficiencies and portfolio diversification are expected following the transaction.
- Closing is anticipated in the second quarter of 2025, subject to regulatory and shareholder approvals.
Moolec Science to Expand Operations Through Business Combination
Moolec Science announced it has signed a Business Combination Agreement with Bioceres Group, Nutrecon, and Gentle Technologies Corp. Under the agreement, the company will issue up to 87 million shares and 5 million warrants in exchange for holdings in the contributed entities.
Upon completion, Moolec Science will operate an expanded platform that integrates molecular farming, biological agricultural solutions, and biomanufacturing services across multiple sectors.
Federico Trucco, board member of Bioceres Group and CEO of Bioceres Crop Solutions, commented, “The need to accelerate agricultural innovation to address current and future challenges is increasingly evident. Molecular farming, as exemplified by Moolec Science, offers a compelling solution to balance productivity and sustainability.”
Broadens Its Agricultural and Biotech Portfolio
Ingredient Development and Molecular Farming Initiatives
Following the transaction, the company will continue developing its core molecular farming products, including Piggy Sooy™ and GLASO™, and incorporate Nutrecon’s Mycofood™ product line under the Eternal® brand. This expansion is intended to diversify Moolec Science’s offering in the alternative protein and functional food ingredient markets.
Biological Agriculture Solutions and Regenerative Farming Technologies
Through the integration with Bioceres Group, Moolec Science will broaden its portfolio to include biological inputs and climate-resilient seed technologies, such as Rizobacter®, ProFarm®, and the HB4® trait. These offerings are aligned with ongoing efforts to support sustainable agriculture practices.
Moolec Science to Strengthen R&D and Infrastructure Capabilities
Moolec Science will expand its research, development, and contract manufacturing capabilities through Agrality® and Synbio Powerlabs®. This infrastructure is designed to provide support across seed development, field testing, precision fermentation, and regulatory services.
Additionally, through Gentle Technologies Corp, the company will pursue opportunities in biomaterials and autonomous farming equipment, contributing to developments in sustainable agricultural practices.
The Business Combination remains subject to customary closing conditions, including the company’s shareholder approval and regulatory reviews, with completion expected in the second quarter of 2025.
José López Lecube, CFO and Director of Moolec, added, “Becoming part of a larger organization will enable cost efficiencies, revenue growth, and portfolio diversification.”
1 Comment